ArticleJournal of orthopaedic surgery and research2025
Evaluation of cartilage regeneration using a hybrid bilayer scaffold based on omentum: evidence of limited efficacy.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe ideal treatment of osteochondral defects is controversial. Regenerative treatment methods aim to produce ideal scaffolds using different biomaterials. Decellularized extracellular matrix (ECM) containing scaffolds are good options recently. Promising results have been reported with decellularized human omentum xenografts in animal models for tissue regeneration. Mesenchymal stem cells (MSCs) and growth factors also form other parts of the tissue engineering triad for cartilage regeneration The objective of this study is to evaluate the regenerative effects of the decellularised omentum-based scaffold, MSCs and platelet-rich plasma (PRP) in the rat knee articular cartilage model. To our knowledge, this study is the first to evaluate the combined effect of a decellularized human omentum composite scaffold, mesenchymal stem cells, and PRP on osteochondral defect repair.
methodsOsteochondral defects were bilaterally created in the femoral trochlea of 42 rats. The animals were randomly divided into five groups: negative control (C), scaffold only (O), scaffold combined with mesenchymal stem cells (OM), scaffold combined with PRP (OP) and scaffold combined with both MSCs and PRP (OMP). At 12 weeks postoperatively, cartilage repair was assessed by macroscopic and histomorphometric evaluation.
resultsThe O group (p = 0.022) and the OMP group (p = 0.001) showed higher scores than the C group macroscopically. No statistically significant differences were observed between the other group comparisons (p > 0.05). According to the total O'Driscoll evaluation scores, none of the experimental groups showed a significant improvement compared to the C group. However, the OMP group had significantly higher total scores than the group O (p = 0.002). According to the ICRS scoring system, the OMP application showed significantly better surface continuity (p = 0.0314), healthier calcified cartilage formation (p = 0.0327), and higher cell viability (p = 0.0029) compared to group O. The OM group demonstrated improved calcified cartilage structure compared to the O group (p = 0.0429).
conclusionsThe omentum-based scaffold, along with MSCs and PRP orthobiologic interventions applied in a single-dose, 12-week protocol, demonstrated limited efficacy in osteochondral defect regeneration. LEVEL OF EVIDENCE: Level NA-Animal studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.